Novak Rodger
Insider CIK 1682017 · CRSP President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-30 | 2021-07-01 | 25,000 | $165.00 | $4.13M | 573,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-28 | 2021-06-30 | 25,000 | $156.55 | $3.91M | 598,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 1,171 | $125.58 | $147.1K | 646,836 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 2,969 | $127.71 | $379.2K | 642,986 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 881 | $126.62 | $111.6K | 645,955 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 12,630 | $128.76 | $1.63M | 630,356 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 50 | $130.27 | $6.5K | 623,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2021-06-21 | 2021-06-23 | 7,299 | $129.46 | $944.9K | 623,057 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-11-30 | 2020-12-02 | 50,000 | — | $0 | 61,893 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-11-30 | 2020-12-02 | 50,000 | — | $0 | 140,315 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-11-30 | 2020-12-02 | 50,000 | $14.43 | $721.5K | 698,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-11-30 | 2020-12-02 | 50,000 | $125.00 | $6.25M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-11-30 | 2020-12-02 | 50,000 | $125.00 | $6.25M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-11-30 | 2020-12-02 | 50,000 | $14.00 | $700.0K | 698,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-10-09 | 2020-10-13 | 2,762 | — | $0 | 190,315 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-10-09 | 2020-10-13 | 2,762 | $100.00 | $276.2K | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-10-09 | 2020-10-13 | 2,762 | $14.43 | $39.9K | 650,769 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-10-08 | 2020-10-13 | 22,238 | — | $0 | 193,077 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-10-08 | 2020-10-13 | 22,238 | $14.43 | $320.9K | 670,245 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-10-08 | 2020-10-13 | 22,238 | $100.00 | $2.22M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-09-01 | 2020-09-03 | 3,933 | — | $0 | 111,893 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-09-01 | 2020-09-03 | 21,067 | — | $0 | 215,315 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 19,754 | $92.59 | $1.83M | 651,847 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-09-01 | 2020-09-03 | 3,933 | $14.00 | $55.1K | 651,940 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 3,840 | $93.19 | $357.8K | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-09-01 | 2020-09-03 | 1,406 | $91.54 | $128.7K | 671,601 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-09-01 | 2020-09-03 | 21,067 | $14.43 | $304.0K | 673,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-08-19 | 2020-08-21 | 25,000 | — | $0 | 115,826 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-08-19 | 2020-08-21 | 25,000 | $100.00 | $2.50M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-08-19 | 2020-08-21 | 25,000 | $14.00 | $350.0K | 673,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-07-07 | 2020-07-09 | 19,414 | — | $0 | 140,826 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2020-07-07 | 2020-07-09 | 5,586 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-07-07 | 2020-07-09 | 19,414 | $14.00 | $271.8K | 673,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2020-07-07 | 2020-07-09 | 5,586 | $1.81 | $10.1K | 653,593 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-07-07 | 2020-07-09 | 25,000 | $90.00 | $2.25M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-07-01 | 2020-07-06 | 50,000 | $80.00 | $4.00M | 648,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-06-23 | 2020-06-25 | 50,000 | $75.00 | $3.75M | 698,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-26 | 2020-05-27 | 36,616 | $70.27 | $2.57M | 748,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-22 | 2020-05-27 | 13,384 | $70.01 | $937.0K | 784,623 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2020-05-19 | 2020-05-21 | 50,000 | $65.00 | $3.25M | 798,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2019-11-19 | 2019-11-21 | 33,618 | — | $0 | 236,382 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2019-11-19 | 2019-11-21 | 33,618 | $14.43 | $485.1K | 33,618 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-11-19 | 2019-11-21 | 33,618 | $70.00 | $2.35M | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-07-10 | 2019-07-12 | 50,000 | $50.00 | $2.50M | 848,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-06-10 | 2019-06-12 | 50,000 | $45.00 | $2.25M | 898,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-03-04 | 2019-03-05 | 3,500 | $42.03 | $147.1K | 948,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-03-04 | 2019-03-05 | 8,912 | $41.29 | $368.0K | 951,507 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-03-04 | 2019-03-05 | 64,115 | $40.24 | $2.58M | 960,419 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-03-01 | 2019-03-05 | 8,693 | $40.01 | $347.8K | 1,024,534 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-02-25 | 2019-02-27 | 14,780 | $40.00 | $591.2K | 1,033,227 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-01-09 | 2019-01-10 | 82,690 | $35.01 | $2.89M | 1,048,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2019-01-08 | 2019-01-10 | 17,310 | $35.09 | $607.4K | 1,130,697 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-05-17 | 2018-05-21 | 39,760 | — | $0 | 160,240 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2018-05-17 | 2018-05-21 | 35,240 | — | $0 | 5,586 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-05-17 | 2018-05-21 | 75,000 | $60.00 | $4.50M | 1,148,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-05-17 | 2018-05-21 | 35,240 | $1.81 | $63.8K | 1,183,247 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2018-05-17 | 2018-05-21 | 39,760 | $14.00 | $556.6K | 1,223,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-09-05 | 2017-09-05 | 3,853 | — | $0 | 40,826 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-09-05 | 2017-09-05 | 3,853 | $1.81 | $7.0K | 1,151,860 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-09-05 | 2017-09-05 | 3,853 | $20.33 | $78.3K | 1,148,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-31 | 2017-09-05 | 14,617 | $20.87 | $305.1K | 1,148,007 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-08-30 | 2017-08-30 | 5,722 | — | $0 | 44,679 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-30 | 2017-08-30 | 58,103 | $20.31 | $1.18M | 1,162,624 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-08-30 | 2017-08-30 | 5,722 | $1.81 | $10.4K | 1,220,727 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-08-28 | 2017-08-30 | 17,692 | — | $0 | 50,401 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-08-28 | 2017-08-30 | 17,692 | $20.06 | $354.9K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-08-28 | 2017-08-30 | 17,692 | $1.81 | $32.0K | 1,232,697 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-22 | 2017-06-23 | 10,825 | — | $0 | 68,093 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-22 | 2017-06-23 | 10,825 | $15.37 | $166.4K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-22 | 2017-06-23 | 10,825 | $1.81 | $19.6K | 1,225,830 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-21 | 2017-06-21 | 11,578 | — | $0 | 78,918 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-21 | 2017-06-21 | 11,578 | $1.81 | $21.0K | 1,266,583 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-21 | 2017-06-21 | 11,578 | $15.02 | $173.9K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-20 | 2017-06-21 | 3,252 | — | $0 | 90,496 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-20 | 2017-06-21 | 3,252 | $15.00 | $48.8K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-20 | 2017-06-21 | 3,252 | $1.81 | $5.9K | 1,218,257 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-19 | 2017-06-21 | 15,392 | — | $0 | 93,748 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-19 | 2017-06-21 | 15,392 | $15.00 | $230.9K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-19 | 2017-06-21 | 15,392 | $1.81 | $27.9K | 1,230,397 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-06-15 | 2017-06-19 | 270,000 | — | $0 | 270,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-09 | 2017-06-12 | 1,100 | — | $0 | 109,140 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-09 | 2017-06-12 | 1,100 | $15.08 | $16.6K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-09 | 2017-06-12 | 1,100 | $1.81 | $2.0K | 1,216,105 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-06-08 | 2017-06-12 | 4,203 | — | $0 | 110,240 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-06-08 | 2017-06-12 | 4,203 | $1.81 | $7.6K | 1,219,208 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-06-08 | 2017-06-12 | 4,203 | $15.00 | $63.0K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-30 | 2017-06-01 | 3,650 | — | $0 | 114,443 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-30 | 2017-06-01 | 3,650 | $15.02 | $54.8K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-30 | 2017-06-01 | 3,650 | $1.81 | $6.6K | 1,218,655 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-17 | 2017-05-18 | 25,923 | — | $0 | 118,093 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-17 | 2017-05-18 | 25,923 | $16.03 | $415.5K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-17 | 2017-05-18 | 25,923 | $1.81 | $46.9K | 1,240,928 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-16 | 2017-05-18 | 24,077 | — | $0 | 144,016 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-16 | 2017-05-18 | 24,077 | $1.81 | $43.6K | 1,239,082 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-16 | 2017-05-18 | 24,077 | $16.50 | $397.3K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-05 | 2017-05-09 | 616 | — | $0 | 168,093 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-05 | 2017-05-09 | 616 | $16.92 | $10.4K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-05 | 2017-05-09 | 616 | $1.81 | $1.1K | 1,215,621 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-04 | 2017-05-04 | 13,191 | — | $0 | 168,709 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-04 | 2017-05-04 | 13,191 | $16.37 | $215.9K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-04 | 2017-05-04 | 13,191 | $1.81 | $23.9K | 1,229,196 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-03 | 2017-05-04 | 20,269 | — | $0 | 181,900 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-03 | 2017-05-04 | 20,269 | $1.81 | $36.7K | 1,235,274 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-03 | 2017-05-04 | 1,022 | $16.64 | $17.0K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-03 | 2017-05-04 | 19,247 | $16.05 | $308.9K | 1,216,027 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-05-02 | 2017-05-04 | 50,000 | — | $0 | 202,169 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-05-02 | 2017-05-04 | 15,924 | $16.53 | $263.2K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-05-02 | 2017-05-04 | 15,924 | $1.81 | $28.8K | 1,230,929 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-04-20 | 2017-04-21 | 2,294 | — | $0 | 218,093 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-04-20 | 2017-04-21 | 2,294 | $1.81 | $4.2K | 1,217,299 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-04-20 | 2017-04-21 | 2,294 | $17.37 | $39.8K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2017-04-19 | 2017-04-21 | 47,706 | — | $0 | 220,387 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-04-19 | 2017-04-21 | 32,338 | $17.57 | $568.2K | 1,230,373 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2017-04-19 | 2017-04-21 | 47,706 | $1.81 | $86.3K | 1,262,711 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2017-04-19 | 2017-04-21 | 15,368 | $18.61 | $286.0K | 1,215,005 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2016-10-18 | 2016-10-20 | 200,000 | — | $0 | 200,000 | SEC↗ |